Biographical Sketch
Raymond Rackley, MD, is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Staff in the Center for Pelvic Health and Reconstructive Surgery within the Glickman Urological and Kidney Institute. Dr. Rackley earned his biomedical engineering degree from Duke University and his medical degree from Case Western Reserve University. He completed a urology residency as well as fellowship training in voiding dysfunction and female urology at Cleveland Clinic. He currently holds Staff appointments in the Glickman Urological and Kidney Institute, the Department of Obstetrics and Gynecology, and the Lerner Research Institute as Director of the basic science Urothelial Biology Laboratory.
Dr. Rackley’s primary focus is on the clinical care of people with pelvic health disorders and the education of those who serve to improve pelvic health. In addition to his full-time clinical responsibilities, he actively manages an NIH and extramurally funded research laboratory for reconstructive and basic science investigations of the lower urinary tract.
During his leadership tenure within the Center of Pelvic Health and Reconstructive Surgery, the Center has evolved as one of the premier centers for national and international educational forums for residents, fellows and postgraduate physicians pursuing expansion of their basic science and clinical knowledge supporting their practices in pelvic health. Dr. Rackley’s programmatic developments for the Center includes formal preceptorships and CME courses held annually for urology residents, fellows and postgraduate urologists, as well as guest preceptorships in clinical practice development and surgical training in pelvic health. He enjoys formal and informal didactic, as well as live, surgical telecast training forums of traditional and minimally invasive procedures such as laparoscopic approaches to pelvic reconstruction.
Dr. Rackley serves as the Principal Investigator and Co-Principal Investigator on NIH grants, as well as other extramural foundation and society grants that focus on bladder health and pelvic organ reconstructive developments. He has also authored or co-authored more than 100 peer-reviewed publications in clinical and basic science topics in pelvic health and urology including numerous chapters in the leading textbooks on urology and pelvic reconstructive surgery. He serves as a reviewer for the leading peer-reviewed national and international urology and gynecology journals, grant reviewer for foundations such as the National Kidney Foundation, and a committee member for the Data and Safety Monitoring Board for the NIH Clinical Research Trials Network for Interstitial Cystitis and Chronic Pelvic Pain and the Bladder Advisory Council of the AUA Foundation. He was recently elected to the Executive Board of the Society of Female Urology and Urodynamics.
Specialty Interests
bladder retention, complex or previously failed incontinence conditions including males, interstitial cystitis, laparoscopic and robotic female prolapse and reconstructive surgery, neuromodulation for bladder and bowel dysfunction, neurourology, regenerative and stem cell based therapies for incontinence, prolapse
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 8/6/2008, Dr.
Rackley has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Rackley receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Allergan Sales, LLC
Novartis
Pfizer Inc.
Proctor and Gamble
GMD, LLC
Equity. Dr. Rackley owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:
GMD, LLC
NDI, LLC
Fiduciary Role. Dr. Rackley serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:
GMD, LLC
NDI, LLC
